TheProfitWatch

BOLT - Bolt Biotherapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
5.77 0.24 (4.07%) --- --- --- -0.21 (-3.64%) 0.08 (1.44%) 0.0 (0.0%) -0.49 (-8.1%)

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-4.46
Diluted EPS:
-4.46
Basic P/E:
-1.3464
Diluted P/E:
-1.3464
RSI(14) 1m:
100.0
VWAP:
6.01
RVol:
0.3263

Events

Period Kind Movement Occurred At
Day Price increase day 6.38 +0.61 (+10.56%) Oct 15 10:28
60m Price increase 60m 5.92 +0.36 (+6.47%) Oct 15 09:30

Related News